With a robust background in technology and healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. Emphasizing a data-driven approach, they have built a diverse portfolio that includes key exits in the biotech sector and successful tech startups. Their strategic focus on early-stage companies allows for a hands-on, operator-first style of investment, fostering innovation and growth. This combination of regional expertise and sector knowledge positions them as a leader in identifying high-potential opportunities.